Genenta Science SpA
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | – | +188.2% | +17.7% | +595.5% | +11.5% | -42.0% | |
| – | – | – | – | – | – | – | |
| – | +19.5% | -19.0% | +47.5% | +22.0% | -21.0% | -48.4% | |
| – | -2.1% | +154.7% | +148.4% | -7.8% | -5.8% | -21.1% | |
| – | +14.1% | +13.9% | +82.0% | +6.5% | -11.6% | -37.8% | |
| – | – | – | – | – | – | – | |
| – | -18.8% | +51.1% | +21,803.6% | – | – | – | |
| – | – | – | – | – | – | – | |
| – | +43.6% | +128.7% | -15,568.5% | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.